<DOC>
	<DOCNO>NCT00221429</DOCNO>
	<brief_summary>This study compare efficacy lithium , divalproex , placebo treat acute phase symptomatic bipolar I disorder , mixed manic episode , child adolescent .</brief_summary>
	<brief_title>Lithium Versus Divalproex Treating Pediatric Bipolar Disorder</brief_title>
	<detailed_description>Primary Aim : To compare efficacy LI , DVP , PBO acute phase treatment symptomatic bipolar I disorder , mixed manic episode , child adolescent . Our hypothesis differential efficacy observe follow predict order response : DVP = LI &gt; PBO . Secondary Aims : 1 . To collect systematic safety data incidence weight gain development insulin resistance hyperandrogenism bipolar adolescent female treat LI , DVP , LI + DVP . 2 . To collect data possible predictor acute treatment response two active treatment . 3 . To provide descriptive information stability acute phase response monotherapy either LI DVP 6 month continuation phase treatment . 4 . To develop safety efficacy data use stimulant medication subject treat mood stabilizer .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>1 . 7.0 – 17 year age 2 . Bipolar I Disorder , mixed manic episode , psychotic nonpsychotic , accord DSM IV criteria 3 . Score &gt; 14 YMRS 4 . Normal intelligence 5 . Ability willingness provide assent inform , write consent least one parent legal guardian 6 . No current general medical illness require medication 1 . A current lifetime DSMIV diagnosis schizophrenia , autistic disorder , schizoaffective disorder , pervasive developmental disorder , obsessive compulsive disorder 2 . IQ &lt; 70 3 . Patients serious suicide risk 4 . Concurrent cognitivebehavior therapy specifically focus child adolescent ’ bipolar symptom within 6 week enrol trial . 5 . Any use psychotropic agent within precede 2 week , include neuroleptic , monoamine oxidase inhibitor , stimulant , antidepressant , depot neuroleptic fluoxetine past month 6 . Current history past 3 month DSMIV diagnosis Substance Abuse/Dependence use illicit drug alcohol past 3 week . Patients positive drug screen intake , would otherwise eligible study , give opportunity repeat drug screen 3 week later . They exclude second drug screen positive . 7 . Pregnancy sexually active female use reliable form contraception 8 . Previous adequate trial either LI DVP define ; 3 week DVP serum level 75125 OR dosage least 20 mg/kg ; Lithium least 4 week serum level .8 – 1.2 dosage least 30 mg/kg . 9 . Allergies LI , DVP chlorpromazine . 10 . Bipolar subject currently stable mood stabilizer atypical neuroleptic . 11 . Bipolar subject Bipolar I disorder ADHD stable stimulant without concurrent mood stabilizer . 12 . Inpatient hospitalization within 6 month prior screen . Partial hospitalization acceptable .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
</DOC>